Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
The Unseen Itch: Over Half of Singaporeans With Eczema Struggle With Sleep Loss, Shame and Social Withdrawal Due to Itch 2025-11-26 10:33
Precious Hospital Sdn. Bhd. to Launch Cancer Centre and Hospital in Johor Bahru 2025-11-26 10:00
Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America 2025-11-26 09:06
Professor Chan Heum Park's Team at Hallym University Chuncheon Sacred Heart Hospital Sends Their Self-Developed "BioCabinet" to Space Aboard Nuri Rocket 2025-11-26 07:30
Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition 2025-11-25 23:06
BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan 2025-11-25 22:41
Mabwell Announces First-Patient Dosing for Novel CDH17-Targeting ADC 7MW4911 2025-11-25 22:00
Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis 2025-11-25 22:00
Hong Kong to Host International Summit on Heart and Brain Health, Spotlighting AI and Startup Innovations 2025-11-25 20:54
Exyte completes Pharmaplan integration: A-to-Z execution in GMP facilities 2025-11-25 18:00
Mazdutide 9mg Supplementary Application Accepted for Review by China's NMPA, Potentially Offering a Novel Drug Option for Moderate-to-Severe Obese Population 2025-11-25 17:00
FROM MEDICAL SUPPLIER TO MULTI-INDUSTRY LEADER: LIVINGSTONE INTERNATIONAL'S UNIQUE GROWTH STRATEGY 2025-11-25 05:00
HKeyBio Launches the HKEY-AIDMD 3.0--a Next-Generation Platform to Crack the Toughest Challenge in Autoimmune and Allergy Drug Development: Multi-target Combination Strategy Optimization 2025-11-25 00:30
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition 2025-11-24 23:34
Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release 2025-11-24 23:19
The Volpi Rosse Menarini: The 'Fantastic Ten' are ready for the 2025 - 2026 Season 2025-11-24 22:40
ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics 2025-11-24 22:00
Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint 2025-11-24 20:00
HoneyNaps Accelerates Clinical Trial Pipelines with FDA-Cleared AI "SOMNUM" 2025-11-24 17:24
Beyfortus® (nirsevimab) now available in Malaysia to protect all infants against RSV disease 2025-11-24 16:55